We would like to congratulate our colleagues at Eurofins DiscoverX for their recent patent application approval for improvements to compound screening and evaluation on cellular responses.
Being the first step of the drug development pathway, high-volume compound screening and patented biomap analysis brings scientific value to our clients within the Eurofins BioPharma Services division. As the largest wholly-owned network of laboratories dedicated to the biopharma development in the world, Eurofins BioPharma Services provides true end-to-end solutions to industry.Please download our Eurofins BioPharma Services brochure above for greater detail on all our analytical services. We look forward to continuing collaboration on developing life-changing treatments!